These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3135749)

  • 1. Comparative susceptibility patterns of common clinical isolates to cefoperazone: 1981 to 1987.
    Jenkins SG
    Am J Med; 1988 Jul; 85(1A):52-5. PubMed ID: 3135749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of inoculum size on the activity of cefoperazone-sulbactam against multidrug resistant organisms.
    Chang PC; Chen CC; Lu YC; Lai CC; Huang HL; Chuang YC; Tang HJ
    J Microbiol Immunol Infect; 2018 Apr; 51(2):207-213. PubMed ID: 29037802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou].
    Xiao QZ; Su DH; Jiang JH; Zhong NS
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):132-8. PubMed ID: 15698988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro antibacterial activity of cefoperazone-sulbactam].
    Zhang Y; Zhang J; Zhou L
    Zhonghua Nei Ke Za Zhi; 1995 Oct; 34(10):676-9. PubMed ID: 8731829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the susceptibility of anaerobes to cefoperazone, cefotaxime, and cefoxitin with the thioglycolate broth disk procedure.
    Zabransky RJ; Birk RJ; Kurzynski TA; Toohey KL
    J Clin Microbiol; 1986 Aug; 24(2):181-5. PubMed ID: 3745418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate disks.
    Washington JA II
    J Infect Dis; 1978 May; 137 Suppl():S32-S37. PubMed ID: 349096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the in vitro activity of cefoperazone: a comparison with other beta-lactam antibiotics.
    Wise R; Gillett AP; Andrews JM
    Clin Ther; 1980; 3(Spec Issue):149-55. PubMed ID: 6446391
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative study of the serum bactericidal activity of cefoperazone alone and in combination with amikacin or mezlocillin against gram-negative bacilli and Staphylococcus aureus.
    Lagast H; Klastersky J; Standiford H; Viollier A
    Infection; 1984; 12(3):190-3. PubMed ID: 6432702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative susceptibility studies of clinically isolated Pseudomonas aeruginosa, Escherichia coli and Klebsiella spp to cefoperazone and cefotaxime.
    Lee YH; Hussain ZA; Choong FP
    J Hyg Epidemiol Microbiol Immunol; 1990; 34(3):299-303. PubMed ID: 2125616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surveillance of susceptibility of clinical isolates to cefmetazole between 2000 and 2002].
    Abe T; Sato Y; Sei M
    Jpn J Antibiot; 2003 Dec; 56(6):574-83. PubMed ID: 15007873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cefoperazone-sulbactam combination. In vitro qualities including beta-lactamase stability, antimicrobial activity, and interpretive criteria for disk diffusion tests.
    Jones RN; Barry AL; Thornsberry C; Wilson HW
    Am J Clin Pathol; 1985 Oct; 84(4):496-504. PubMed ID: 2994461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bacteria isolated from surgical infections and their susceptibilities to antimicrobial agents. Special references to bacteria isolated between April 1997 and March 1998].
    Mashita K; Shinagawa N; Sato T; Hirata K; Katsuramaki T; Mukaiya M; Yura J; Ishibiki K; Ushijima Y; Manabe T; Takeyama H; Hasegawa M; Aikawa N; Yamazaki M; Ishikawa S; Iwai S; Kato K; Mizuno A; Kinoshita H; Morimoto K; Konaga E; Takeuchi H; Fujimoto M; Matsuura Y; Takesue Y; Tanimura H; Ohnishi H; Maeda T; Yokoyama T; Hiyama E; Tanaka N; Inoue F; Iwagaki H; Ikeda S; Yasunami Y; Fuchimoto S; Matsumoto Y; Suzuki Y; Tanaka S; Kimura H
    Jpn J Antibiot; 2000 Aug; 53(8):533-65. PubMed ID: 11070817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015.
    Sader HS; Castanheira M; Flamm RK
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28069649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bactericidal activity of ertapenem against major intra-abdominal pathogens.
    Borbone S; Cascone C; Santagati M; Mezzatesta ML; Stefani S
    Int J Antimicrob Agents; 2006 Nov; 28(5):396-401. PubMed ID: 17045463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of clinical isolates of Bacteroides fragilis group strains to cefoxitin, cefoperazone and ticarcillin/clavulanate.
    Peixoto Júnior AA; Rocha MM; Moreira JL; Carvalho CB
    Rev Inst Med Trop Sao Paulo; 2000; 42(3):137-9. PubMed ID: 10887372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro studies with ceftazidime against aerobic gram-negative bacilli and Bacteroides fragilis group.
    Acuna G; Johnston J; Young LS; Martin WJ
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():83-9. PubMed ID: 19810170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
    Mascellino MT; Prignano G; Iegri F; Lorenzi A
    Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of sulperazon against recent isolates of ceftazidime-resistant bacteria.
    Lim VK; Halijah MY
    Med J Malaysia; 2001 Sep; 56(3):365-9. PubMed ID: 11732084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in-vitro activity of ceftazidime compared with that of other cephalosporins.
    Bint AJ; Yeoman P; Kilburn P; Anderson R; Stansfield E
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():47-51. PubMed ID: 19802968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.